Alloplex Biotherapeutics

Boston, United States

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

$20.0M raised

Feb 2023

Series A

Biopharma Biotechnology Health Care Therapeutics

Top Investors

Daewoong PharmaceuticalHanAll Biopharma

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alloplex Biotherapeutics

How much funding has Alloplex Biotherapeutics raised?

Alloplex Biotherapeutics has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in February 2023.

Who are Alloplex Biotherapeutics's investors?

Alloplex Biotherapeutics's investors include Daewoong Pharmaceutical, HanAll Biopharma.

Where is Alloplex Biotherapeutics headquartered?

Alloplex Biotherapeutics is headquartered in Boston, United States.

What does Alloplex Biotherapeutics do?

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

What stage is Alloplex Biotherapeutics at?

Alloplex Biotherapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 14, 2023.

MLA

"Alloplex Biotherapeutics — Funding & Investors." VCBacked, February 14, 2023, https://www.vcbacked.co/company/alloplex-biotherapeutics. Accessed June 13, 2026.

APA

VCBacked. (2023). Alloplex Biotherapeutics — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/alloplex-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Alloplex Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alloplex-biotherapeutics |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 14, 2023.